Drew Hillier, associate in the firm's Litigation section, co-authored an article for The Center for Biosimilars, “Legal Opinion: BPCIA Is Likely to Survive Latest ACA Challenge.”
We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.
Already a subscriber and want to update your preferences? Click here.